|
News & Events
April 30, 2012
Final Results Statement
April 30, 2012
2011 Annual Report and Accounts
March 28, 2012
Asterand's Subsidiary BioSeek Extends Collaboration with Merck Serono
March 12, 2012
BioMAP® Profiling Provides Insights into Toxicity of Nanomaterials, Failed Drugs and Environmental Chemicals
March 6, 2012
Update on Formal Sale Process
Feburary 2012
EPA Expands Innovative Compound-Testing Collaboration With BioSeek
January, 2012
Asterand Subsidiary BioSeek and US EPA Expand ToxCastTM Collaboration
November 30, 2011
Asterand's Subsidiary BioSeek Achieves A Research Milestone In Drug Discovery Collaboration With Ono
June 8, 2011
Asterand Introduces New Human 3D Model for Diabetes Research
May 17, 2011
Interim Management Statement
May 4, 2011
Replay the Asterand plc 2010 Final Results Announcement Webcast
April 28, 2011
Asterand Releases 2010 Annual Report and Accounts
April 28, 2011
Asterand's Final Results Statement
April 28, 2011
Asterand Announces New Financing Arrangements
March 31, 2011
Asterand Awarded Key Patents on the BioMAP® Technology
March 29, 2011
Asterand and 5AM Solutions Enter a Preferred Partnership Agreement
March 3, 2011
Asterand Receives French Research Tax Credit Accreditation
BioMAP® Systems are integrated cell systems that generate a unique signature of human biological response for prediction of mechanisms and therapeutic efficacy. More...
|
